COVID-19 news is changing rapidly and we are all trying to stay on top of the latest medical information from trusted sources. Join experts in the medical field for free CME webinars covering what we know about the coronavirus outbreak.
Managing MS in the Era of COVID-19
Join expert faculty Michael Kornberg, MD, PhD, and Elias Sotirchos, MD, as they discuss strategies to keep their patients with MS safe from COVID-19. Topics:
Maintaining care during a pandemic
The impact of MS and DMTs on COVID-19 risk
COVID-19 vaccination in MS patients
Delaying doses or stopping therapy
My patient has COVID-19 – now what?
Credit available: 0.5 of AMA, AAPA, or ANCC
Michael Kornberg, MD, PhD
Assistant Professor Department of Neurology Johns Hopkins School of Medicine Baltimore, MD
Elias Sotirchos, MD
Post-Doctoral Fellow Department of Neurology Johns Hopkins University School of Medicine Baltimore, MD
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.
ostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until December 15, 2022. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Michael Kornberg, MD, PhD
Consulting Fees: Janssen, OptumRx, and Biogen, Inc.
Elias S. Sotirchos, MD
Consulting Fees: Alexion, Genentech, Viela Bio
Speaker Fees: Biogen, Inc., Viela Bio
The PIM planners and others have nothing to disclose. The DKBmed planners and others have nothing to disclose.
If you have questions regarding the certification of this activity, please contact PIM via email at [email protected].
INSTRUCTIONS FOR PARTICIPATION AND CREDIT
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
Read the CME/CE information and faculty disclosures.
Participate in the online activity.
Submit the evaluation form.
Certificates will be emailed to the participant.
COURSE VIEWING REQUIREMENTS
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.